Skip to main navigation

Prime Medicine Logo

Overview
News & Events
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Corporate Governance
Sec filings
IR Resources

Press Releases

Year

February 28, 2024

Prime Medicine to Participate in Upcoming Investor Conferences

February 20, 2024

Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

February 14, 2024

Prime Medicine Announces Pricing of Upsized Public Offering

February 14, 2024

Prime Medicine Announces Proposed Public Offering of Common Stock

February 1, 2024

Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

January 25, 2024

Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis

January 5, 2024

Prime Medicine and Myeloid Therapeutics Announce Settlement of Pending Disputes

January 5, 2024

Prime Medicine Appoints Allan Reine, M.D., as Chief Financial Officer

January 2, 2024

Prime Medicine to Present at 42nd Annual J.P. Morgan Healthcare Conference

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 19 of 19

Print Page

Email Alerts

RSS Feeds

Contact IR

prime_

Site - Footer Bottom

Contact Us
Privacy Policy
Terms of Use

© 2021-2024 Prime Medicine, Inc. All rights reserved. PRIME MEDICINE and the Prime Medicine logos are trademarks of Prime Medicine, Inc.